Louis Moore Bacon's ABBV Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 60,000 shares of AbbVie Inc. (ABBV) worth $13.89 M, representing 0.19% of the portfolio. First purchased in 2014-Q2, this medium-term investment has been held for 15 quarters.
Based on 13F filings, Louis Moore Bacon has maintained a strategic position in ABBV, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2021, adding 141,739 shares. Largest reduction occurred in Q1 2022, reducing 141,739 shares.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's AbbVie (ABBV) Holding Value Over Time
Track share changes against reported price movement
Quarterly AbbVie (ABBV) Trades by Louis Moore Bacon
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2014 | +185,000 | New Buy | 185,000 | $56.44 |
| Q3 2014 | -105,000 | Reduce 56.76% | 80,000 | $57.76 |
| Q4 2014 | -49,956 | Reduce 62.44% | 30,044 | $65.44 |
| Q1 2015 | -30,044 | Sold Out | 0 | $0.00 |
| Q2 2015 | +25,000 | New Buy | 25,000 | $67.20 |
| Q3 2015 | -25,000 | Sold Out | 0 | $0.00 |
| Q4 2015 | +36,243 | New Buy | 36,243 | $59.24 |
| Q1 2016 | -36,243 | Sold Out | 0 | $0.00 |
| Q4 2021 | +141,739 | New Buy | 141,739 | $135.40 |
| Q1 2022 | -141,739 | Sold Out | 0 | $0.00 |
| Q3 2023 | +60,000 | New Buy | 60,000 | $149.06 |
| Q4 2023 | -60,000 | Sold Out | 0 | $0.00 |
| Q1 2025 | +45,000 | New Buy | 45,000 | $209.52 |
| Q2 2025 | +55,000 | Add 122.22% | 100,000 | $185.62 |
| Q3 2025 | -40,000 | Reduce 40.00% | 60,000 | $231.54 |
Louis Moore Bacon's AbbVie Investment FAQs
Louis Moore Bacon first purchased AbbVie Inc. (ABBV) in Q2 2014, acquiring 185,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon has held AbbVie Inc. (ABBV) for 15 quarters since Q2 2014.
Louis Moore Bacon's largest addition to AbbVie Inc. (ABBV) was in Q2 2014, adding 185,000 shares worth $10.44 M.
According to the latest 13F filing for Q3 2025, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 60,000 shares of AbbVie Inc. (ABBV), valued at approximately $13.89 M.
As of the Q3 2025 filing, AbbVie Inc. (ABBV) represents approximately 0.19% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings.
Louis Moore Bacon's peak holding in AbbVie Inc. (ABBV) was 185,000 shares, as reported at the end of Q2 2014.